Mendel vs Figma
Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinical trial AI platform extracting structured insights from unstructured medical records; NLP for patient eligibility matching, pharmacovigilance, and real-world evidence generation.
About
Mendel is a clinical trial data management and AI platform that accelerates pharmaceutical and biotech drug development by extracting structured insights from unstructured medical records — physician notes, pathology reports, lab results, and clinical documentation — using natural language processing to identify patients eligible for trials, adverse events, and endpoint assessments. Founded in 2017 and headquartered in San Francisco, Mendel raised approximately $35 million and serves life sciences companies, hospital systems, and CROs (contract research organizations) running clinical trials.
Dominant browser-based collaborative UI design platform at ~$600M ARR and $12.5B valuation; Adobe's $20B acquisition blocked by regulators in 2023, Figma remains independent competing with Sketch and Adobe.
About
Figma is a San Francisco-based collaborative web-based product design platform that has become the dominant tool for UI/UX designers and product teams — enabling real-time multi-user collaboration on interface design, prototyping, and design system management directly in the browser without installing desktop software. Founded in 2012 by Dylan Field and Evan Wallace and backed by Sequoia, Greylock, and Andreessen Horowitz with over $330 million raised, Figma generated approximately $600 million in ARR in 2023, serving 4 million+ designers and product teams at companies including Microsoft, Airbnb, Twitter, and Uber. Adobe announced a $20 billion acquisition offer in 2022, which was blocked by regulators in 2023 — Figma remains independent.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.